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Synthesis of trifluoromethylated isoxazoles
and their elaboration through inter- and
intra-molecular C–H arylation†
Jian-Siang Poh,a Cristina García-Ruiz,a Andrea Zúñiga,a Francesca Meroni,a
David C. Blakemore,b Duncan L. Browne*a,c and Steven V. Leya
We report conditions for the preparation of a range of trifluoromethylated isoxazole building blocks
through the cycloaddition reaction of trifluoromethyl nitrile oxide. It was found that controlling the rate
(and therefore concentration) of the formation of the trifluoromethyl nitrile oxide was Critical for the pre-
ferential formation of the desired isoxazole products versus the furoxan dimer. Different conditions were
optimised for both aryl- and alkyl-substituted alkynes. In addition, the reactivity at the isoxazole 4-posi-
tion has been briefly explored for these building blocks. Conditions for intermolecular C–H arylation,
lithiation and electrophile quench, and alkoxylation were all identified with brief substrate scoping that
signifies useful tolerance to a range of functionalities. Finally, complementary processes for structural
diversification through either intramolecular cyclisation or intermolecular cross-coupling were developed.
Introduction
The addition of fluorine to organic molecules does a great deal
to alter chemical properties and behavior.1 For example, in
biologically active materials fluorine substituents can affect
the charge distribution, electrostatic surface and solubility of
chemical entities, often leading to positive outcomes.2 Perhaps
the most attractive property however is the ability to reduce the
rate of metabolism compared to non-fluorous congeners,
which ultimately leads to reduced dosing rates for both
patients and crops.3 Furthermore, in the area of materials
chemistry fluorous substituents can impart advantages such
as reduced band gaps and higher quantum efficiencies in
OLED devices.4
There are typically two strategic methods for introducing
fluorous substituents. The late stage introduction, which has
received much attention recently,5 is an important method,
particularly for taking advantage of the radioactive properties
of 18F labelled materials.6 Furthermore, with regards to
trifluoromethylation, this doctrine serves as a convenient
method to easily functionalise existing compound libraries,
usually through a C–H, C–O, C–B, C–Sn or C–X bond trans-
formation and more recently that of a C–N bond.7 Alterna-
tively, a strategy involving the preparation of novel fluorinated
building blocks which are then incorporated in a convergent
manner (a fluorous synthon approach) is also of importance,
particularly when it comes to scaling up the preparation of the
compound of interest.8 Common to both strategic approaches
is the fact that fluorine is not present in many naturally occur-
ring organic compounds and so any reagents or building
blocks must be derived from fluorine gas, or other mineral
derived fluorines (such as HF, SF4, SF6 or HOF) thus requiring
both highly skilled workers and specialised equipment and
safety protocols.
Recently, we and others have been exploring cycloaddition
methods to rapidly access a series of fluorinated intermediates,
from simple fluorous synthon starting materials, that can further
undergo a range of diverse modifications.9 Here we report a
robust protocol for the preparation and cycloaddition of trifluoro-
acetonitrile oxide with alkynes, followed by diversification via
palladium-catalysed inter- and intra-molecular C–H activation
reactions. We have also assessed the further derivatisation of
these systems via anion and cycloaddition chemistry.
Scheme 1 Preparation of CF3 nitrile oxide precursor.
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Results and discussion
Our approach to the preparation of 3-trifluoromethyl isox-
azoles hinged on a nitrile-oxide [3 + 2] cycloaddition reaction
with alkyne substrates. Few examples of this approach are
known. In order to synthesize the desired 5-substituted
3-trifluoromethylated isoxazoles via [3 + 2] cycloaddition reac-
tions, a stable nitrile oxide precursor for trifluoroacetonitrile
oxide was required. We decided to use hydroximoyl bromide 3,
prepared using a two-step procedure (Scheme 1) from the com-
mercially available trifluoromethylated hemiacetal 1.10 Owing
to the volatility of both intermediate aldoxime 2 and hydroxi-
moyl bromide 3, these materials were extracted into an ethe-
real solution and then stored and used from this stock in
subsequent steps.11
With the desired trifluoromethyl nitrile oxide precursor in
hand, we then focused on the [3 + 2] cycloaddition reaction
with terminal alkynes. Early attempts with the cycloaddition
reaction under similar conditions reported by Tanaka et al.
with a small variety of alkynes revealed that the yield of isox-
azole was rather dependent on the electronic properties of the
alkyne (Table 1).12 In general, more electron-deficient alkynes
(in particular, alkyl alkynes) appeared to undergo slower cyclo-
addition with trifluoroacetonitrile oxide. Analysis of the 19F
NMR spectra of the crude reaction mixture for some alkyl
alkynes (Scheme 2) indicated the presence of furoxan resulting
from the unwanted dimerization reaction of trifluoroaceto-
nitrile oxide.13
We considered the rates of the reactions explored in the
context of these experimental observations. Empirically, the
preliminary evidence suggests that the rate of nitrile oxide
cycloaddition with aryl alkynes is greater or comparable to that
of the dimerization of the CF3 nitrile oxide, whereas the rate of
cycloaddition between the nitrile oxide and alkyl alkynes
appears to be slower than the rate of furoxan formation. This
suggested that control could be obtained by reducing the con-
centration of nitrile oxide relative to alkyne. Such control could
potentially be achieved by invoking pseudo first-order conditions
in nitrile oxide. This would be achieved by using a syringe pump
to deliver either the base or the nitrile oxide precursor slowly to a
flask containing all of the alkyne. With this in mind we therefore
optimized procedures for aryl and alkyl alkynes separately, with
particular attention to methods that limit formation of the
Table 1 Optimisation for aryl alkyne cycloaddition
Entry
Alkyne
equiv. (X)
Addition
rate (Y) Base/solvent Yielda
1 1.0 45 Et3N/PhMe 70%
2 2.0 45 Et3N/PhMe 90%
3 3.8 45 Et3N/PhMe 93%
4 2.0 45 iPr2NEt/PhMe 69%
5 2.0 45 Pyridine/PhMe 9%
6 2.0 45 2,6-Lutidine/PhMe 5%
7 2.0 45 TBAF/THF 2%
8 2.0 45 Na2CO3/H2O 82%
9 2.0 5 Et3N/PhMe 81%
10 2.0 120 Et3N/PhMe 96%
a Yield of isolated product.
Scheme 2 Initial cycloaddition experiments and considerations.
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furoxan. For the optimization studies of aryl alkyne cycloaddi-
tions, we used phenylacetylene as the substrate. Firstly, the
number of equivalents of alkyne was assessed.
With 1.1 equiv. of alkyne and dropwise addition via syringe
pump of 2 equiv. Et3N/PhMe over 45 min at r.t. (Table 1, entry
1), the corresponding isoxazole 5a was isolated in 70% yield.
Analysis of the crude reaction mixture by 19F NMR spec-
troscopy indicated the presence of furoxan. Increasing the
alkyne equivalents to 2.0 and 3.8 gave yields of 90% and 93%
respectively (Table 1, entries 2 and 3), indicating that an excess
of alkyne relative to the nitrile oxide would be advantageous to
suppressing furoxan formation. We decided to use 2.0 equiv.
of alkyne for subsequent reactions as it appeared that greater
excesses of alkyne provided diminishing returns in terms of
yield of desired isoxazole product. When a variety of bases
were assessed only Et3N,
iPr2NEt and Na2CO3 provided good
yields of isoxazole 5a (Table 1, entries 3, 4 and 8), whereas
weaker bases such as pyridine, 2,6-lutidine and TBAF pro-
duced negligible yields of 5a (Table 1, entries 5–7). Finally, the
rate of base addition was assessed; when the time taken for
addition of Et3N was decreased to 5 min, isoxazole 5a was iso-
lated in 81% yield (Table 1, entry 9). However, when the time
taken was increased to 2 h, isoxazole 5a was isolated in an
improved yield of 96% (Table 1, entry 10).
Evidently, using a slower rate of base addition to controll-
ably unveil small amounts of nitrile oxide could further sup-
press the unwanted dimerisation reaction, since the relative
concentration of the nitrile oxide compared to the alkyne was
low. We then focused our attention on alkyl alkynes using
5-hexynenitrile as the substrate. Since it appeared that suppres-
sion of furoxan formation was required to obtain good yields
of isoxazole, it was postulated that increasing the time taken
for base addition would be a simple modification to the opti-
mized procedure for aryl alkynes. Indeed, when the time taken
for base addition was progressively increased to 16 h (Table 2,
entries 1–3), higher yields of isoxazole 6a were obtained;
further increasing the time taken to 24 h (Table 2, entry 4) had
little effect on yield.14 With optimized conditions for the cyclo-
addition reaction with aryl and alkyl alkynes established, we
decided to explore the scope of the reaction.
For the aryl alkyne examples explored, both electron-rich
and electron-poor systems underwent cycloaddition, with the
latter proceeding in lower yield, perhaps due to a mismatch
in the electronics of the dipolarophile and 1,3-dipole. With
Scheme 4 Scope of the alkyl alkyne cycloaddition.
Scheme 3 Scope of the aryl alkyne cycloaddition.
Table 2 Optimisation for alkyl alkyne cycloadditions
Entry Addition rate (Y) Base/solvent Yielda
1 45 min Et3N/PhMe 38%
2 6 h Et3N/PhMe 58%
3 16 h Na2CO3/H2O 73%
4 24 h Na2CO3/H2O 74%
a Yield of isolated product.
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regard to the alkyl alkynes a variety of functional groups were
tolerated such as alkyl bromides, free alcohols, cyclopropanes,
nitriles and ketones (Scheme 3). In addition, we explored some
more exotic alkyl alkynes derived from nucleophilic aromatic
substitution of heteroaromatic halides with propargyl alcohol.
Of the three explored, all proceeded to the desired product in
yields greater than 50% (Scheme 4, 6i, 6j and 6k). For all of the
explored substrates the cycloaddition reaction showed exclu-
sive regioselectivity for the formation of 5-substituted isox-
azoles, an observation congruent with the literature.15 Several
examples were also conducted on larger scale and afforded
greater than 2.5 grams of product in comparable or greater
yields to the smaller scale reactions (5a, 6d, 6e and 6f ).
Having demonstrated a broad substrate scope we next
wished to explore the possibility of further manipulation of
these 5-substituted 3-trifluoromethylisoxazoles by the intro-
duction of functionality at the 4-position. Palladium-catalyzed
C–H activation of isoxazoles has been demonstrated by Fall
et al. on 3,5-dimethylisoxazole and 3-methyl-5-phenylisoxazole,
but they note that electron-deficient isoxazoles were coupled
much less efficiently.16 Indeed, the intermolecular cross-
coupling of 4-bromotoluene and 5-phenyl-3-trifluoromethyl-
isoxazole (5a) resulted in only 38% conversion to the desired
4-arylated isoxazole (7a), despite use of 5 mol% PdCl2 and
heating for 72 h. However, switching to 2 equiv. aryl bromide
allowed the desired product 7a to be isolated in 85% yield.
Alternative aryl bromide coupling partners for 5-phenyl-3-
trifluoromethylisoxazole (5a), such as electron-rich, electron-
deficient and heterocyclic bromides, were assessed (Scheme 5)
and gave moderate to excellent yields. Further, 5-cyclopropyl-3-
trifluoromethylisoxazole (5g) could also be coupled to
3-bromopyridine in 47% yield. Rather than undergoing cross-
coupling of the C–H bond at the 4-position, lithiation at this
position was also demonstrated using nBuLi.
Again for the 5-phenyl-3-trifluoromethylisoxazole (5a) sub-
strate, lithiation was straightforward (Scheme 6). Quenching of
the thus formed organometallic species with DMF led to the
corresponding aldehyde whereas a boron electrophile
(i-PrOBPin) could be used to afford the boronic ester product
8b in good yields. Notably, whilst the 5-cyclopropyl-3-trifluoro-Scheme 6 Lithiation and electrophilic quench.
Scheme 7 Elimination and nitrile oxide cyclisation.
Scheme 5 Intermolecular C–H arylation.
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methylisoxazole (5g) also participated in this chemistry; the
aldehyde product 8c was isolated in reduced yield compared to
the phenyl analogue.
Other strategies to rapidly elaborate this ring system hinged
around the versatile fluorinated, bromoalkyl building blocks
6d and 6e. Indeed, we found that homobenzylic bromide (6e)
was an excellent surrogate for the 5-alkenyl-3-trifluoromethyl-
isoxazole (9) through an elimination process. This alkene was
most optimally accessed by stirring 6e in the presence of the
polymer-supported base, Ambersep® OH resin, followed by fil-
tration of the resin and storage of the resultant volatile alkene (9)
in an ethereal solution. The reactivity of this versatile alkene
building block (9) was then explored in the context of nitrile
oxide cycloaddition chemistry (Scheme 7). In this instance it is
well documented that the rate of alkene cycloaddition is greater
than that of the nitrile oxide homo-dimerisation process. Indeed,
the nitrile oxide derived from cinnamaldehyde underwent
smooth cycloaddition to give the isoxazole–isoxazoline bicyclic
moiety (10a). Electron-rich and electron-poor benzaldehyde
derivatives also proceeded without incident affording the
4-methoxy and 4-trifluoromethyl variants 10b and 10c in excellent
yield. The cycloaddition reaction of electron-poor alkene building
block 9 with the electron-poor trifluoromethyl nitrile oxide (4)
did also afford the desired isoxazole–isoxazoline bicyclic product,
but in reduced yield (47%) relative to the other examples
explored, again likely due to a mis-match in electronics.
A strategy for derivatisation of the trifluoromethylated
bromoalkyl building block 6d, is described in Scheme 8. The
approach commences by using this material as an alkylating
agent for an aromatic ring bearing a nucleophilic heteroatom
and an adjacent halide function.
The halide on these resulting products could then poten-
tially undergo two different cross-coupling reactions leading to
rapid structural diversification.17
One cross-coupling would be intermolecular and could
likely be controlled by appropriate choice of base and
inclusion of a coupling partner (boronic acid), whereas the
other coupling would be an intramolecular C–H functionaliz-
ing ring formation leading to a novel series of trifluoromethyl-
ated tricyclic scaffolds. Indeed this approach also offers
significant scope for varying linker size in the initial alkylation
step and therefore the subsequent central ring size of the tri-
cyclic system. Commencing with the alkylation of a variety of
ortho-iodophenols with bromide 6d, we found that optimal
conditions consisted of gentle heating to 60 °C in DMF using
potassium carbonate as base (Scheme 9). Conditions for the
Scheme 9 Conditions and scope for alkylation reaction.
Scheme 8 Proposed strategy for rapid structural diversification
through complementary cross-coupling.
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alkylation of ortho-iodobenzyl alcohols were better conducted
with sodium hydride in THF, which furnished several homo-
logated products (Scheme 9). Next we turned to the intra-
molecular C–H arylation reaction and looked to further
develop the cross-coupling conditions. Initially this was inves-
tigated on para-methoxyphenyl substrate 13. Repeating our
previously successful conditions for the intermolecular case
on this substrate afforded 12% isolated yield of the intra-
molecular product (14) but 98% conversion of the starting
material. The main byproduct was that derived from deiodina-
tion (Table 3, entry 1). Exploring DMF and 1,4-dioxane as
solvent options, it was found that in DMF the reaction
afforded an improved 31% yield of the cyclised product
(Table 3, entry 2). Replacement of the KOAc base with K2CO3
and Cs2CO3 did not lead to dramatic changes in yield. Taking
inspiration from the literature on intramolecular C–H arylation
reactions of benzene systems via proton abstraction, we made
a more significant change in our approach.18
Table 3, entries 10–14 describe the results from the
changed catalyst system, now including a ligand, additive and
two further equivalents of base, whilst dropping the tempera-
ture by 30 °C and reaction time down to 1 day. Notably, in
almost all cases the outcome was improved, with tricyclohexyl-
phosphine ligand and tetrabutylammonium bromide as addi-
tive providing the superior result at 57% isolated yield. Indeed,
we surveyed several other literature reports19 and found that
the conditions reported by Fagnou et al. offered further impro-
vements.19a Under these conditions, which included reduced
loading of additive and use of triarylphosphines, we made
gains on both reaction time and temperature where the
optimal conditions consisted of heating to 65 °C over 16 hours
(Table 3, entry 18). Notably, P(4-F-Ph)3 as ligand outperformed
PPh3, providing a 10% improvement in isolated yield (Table 3,
cf. entries 17 and 18). Applying these optimal conditions, as
developed for the less reactive model substrate, to the 3-tri-
fluoroisoxazole 11a we were pleased to find that the tricyclic
product (15a) could be isolated in 90% yield (Table 4, entry 2).
Control reactions showed that P(4-F-Ph)3 still provides notable
benefit as does the presence of pivalic acid. With these
optimal conditions, we then applied them to a range of the
alkylated materials to successfully furnish a range of 5,6,6 tri-
cyclic compounds including the pyridine derivatives 15c and
15f in moderate to excellent yields (Scheme 10). One example
of a 5,7,6 tricycle (15h) was also prepared in 60% yield using
these C–H arylation conditions.
In order to demonstrate the diversity of this scaffold
through cross-coupling we also found optimal conditions for
the intermolecular Suzuki–Miyaura reaction. Inclusion of the
requisite boronic acid and switching both the base and solvent
system permitted smooth access to the linear products 16a–d
in good to excellent yield. Notably in the latter cross-coupling
cases, no intramolecular cyclised product was detected signal-
ling that the reactivity and structural diversity can truly be
switched by a simple change in reaction conditions.
Table 3 Optimisation of the intramolecular C–H arylation reaction (model substrate)
Entry Base Solvent Ligand Additive Time (h) Conversion Isol. yield
PdCl2 (5 mol%); base (2.0 equiv.);
solvent, 130 °C
1 KOAc DMA — — 72 98 12
2 DMF — — 48 98 31
3 Dioxane — — 48 —a —
4 K2CO3 DMA — — 72 —
a —
5 DMF — — 72 — 21
6 Dioxane — — 72 —a —
7 Cs2CO3 DMA — — 72 —
a —
8 DMF — — 72 — 40
9 Dioxane — — 72 —a —
Pd(OAc)2 (5 mol%); base (4.0 equiv.);
ligand, additive (2.0 equiv.); solvent, 100 °C
10 K2CO3 DMF PCy3 TBAB 24 98 57
11 DMF dppf TBAB 24 98 0
12 DMA PtBu3·HBF4 TBAB 24 98 42
13 DMA PCy3·HBF4 TBAB 24 98 36
14 DMA Xantphos — 24 98 52
Pd(OAc)2 (5 mol%); base (4.0 equiv.);
ligand, additive (0.3 equiv.); solvent, 65 °C
15 K2CO3 DMA P(Ph)3 TMBA 16 98 47
16 DMA P(Ph)3 PhCO2H 16 98 38
17 DMA P(Ph)3 PivOH 16 98 51
18 DMA P(4-F-Ph)3 PivOH 16 98 60
19 DMA P(4-Cl-Ph)3 PivOH 16 98 44
a Starting material recovered.
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Conclusions
In summary, we report conditions for the preparation of a range
of trifluoromethylated isoxazole building blocks though trifluoro-
methyl nitrile oxide cycloaddition. It was found that controlling
the rate (and therefore concentration) of the formation of the tri-
fluoromethyl nitrile oxide was critical for the preferential for-
mation of the desired isoxazole products versus the furoxan
dimer. Different conditions were optimised for both aryl- and
alkyl-substituted alkynes. In addition, the reactivity at the isox-
azole 4-position was then briefly explored for these building
blocks. Conditions for intermolecular C–H arylation, lithiation
and electrophile quench, and alkoxylation were all identified
with brief substrate scoping that signifies useful tolerance to a
range of functionalities. Finally we developed complementary
processes for structural diversification through either intra-
molecular cyclisation or intermolecular cross-coupling, with a
series of 5,6,6 and 5,6,7 tricyclic systems being formed.
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